 |
|
|
| |
HIV-1 Attachment Inhibitor Prodrug BMS-663068 in Antiretroviral-Experienced Subjects: Week 24 Subgroup Analysis and Safety Profile - oral presentation
|
| |
| |
Reported by Jules Levin
HIV Glasgow 2014 Nov 2-6
J Lalezari,1 C Brinson,2 GH Latiff,3 J Echevarría,4 M Thompson,5
S Trevino-Pérez,6 JR Bogner,7 D Stock,8 SR Joshi,8 GJ Hanna,9
M Lataillade8
for the AI438011 study team
1. Quest Clinical Research, San Francisco, CA, US; 2. Central Texas Clinical Research, Austin, TX, USA; 3. Maxwell Clinic, Durban, South Africa; 4. Hospital Nacional Cayetano Heredia, Lima, Peru;
5. AIDS Research Consortium of Atlanta, Atlanta, USA; 6. Mexico Centre for Clinical Research, Mexico City, Mexico; 7. Hospital of the University of Munich, Munich, Germany 8. Bristol-Myers Squibb, Wallingford, CT, USA; 9. Bristol-Myers Squibb, Princeton, NJ, USA
|
| |
|
|
|
|
|
